Passa al contenuto
Merck

Vai a

A6476

ABT-418 hydrochloride

powder, ≥98% (HPLC)

Sinonimo/i:

3-Methyl-5-[(2S)-1-methyl-2-pyrrolidinyl]isoxazole hydrochloride

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Voi/SKUDisponibilitàPrezzo
25 mg
Per conoscere la disponibilità, visualizza il carrello
CHF 619.00

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C9H14N2O · HCl
Numero CAS:
Peso molecolare:
202.68
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
51111800
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated

CHF 619.00


Per conoscere la disponibilità, visualizza il carrello

Richiedi un ordine personalizzato
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


Quality Segment

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

solubility

H2O: soluble 15 mg/mL

originator

Abbott

SMILES string

Cl.CN1CCC[C@H]1c2cc(C)no2

InChI

1S/C9H14N2O.ClH/c1-7-6-9(12-10-7)8-4-3-5-11(8)2;/h6,8H,3-5H2,1-2H3;1H/t8-;/m0./s1

InChI key

VOXHERKWAIEJQF-QRPNPIFTSA-N

General description

ABT-418 is an α4β2 agonist of nicotinic receptors.

Application

ABT-418 hydrochloride has been used as a nicotinic acetylcholine receptor (nAChR) agonist to test its effect on spatial memory improvement in attention deficit hyperactivity disorder (ADHD) rat model
ABT-418 [(S)-3-methyl-5-(1 methyl-2-pyrrolidinyl)isoxazole hydrochloride] is a novel neuronal nicotinic acetylcholine receptor (nAChR) ligand with cognitive enhancing and anxiolytic-like activity 3- to 10-fold more potent than (-)-nicotine in rodents. ABT-418 hydrochloride has been used to study new therapeutic approaches for the treatment of Alzheimer′s disease.

Biochem/physiol Actions

Neuronal nicotinic acetylcholine receptor agonist with cognition enhancing and anxiolytic activities.

Features and Benefits

This compound is featured on the Acetylcholine Receptors (Nicotinic) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Abbott. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Legal Information

Subject to U.S. Patent No. 5409946 and sold under license from Abbott Laboratories.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
SML2660L1011E101
description

powder, ≥98% (HPLC)

description

≥98% (HPLC)

description

>98% (TLC), powder

description

≥98% (HPLC), powder

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

>98% (TLC)

assay

≥98% (HPLC)

form

powder

form

powder

form

powder

form

powder

Quality Level

100

Quality Level

100

Quality Level

200

Quality Level

100

solubility

H2O: soluble 15 mg/mL

solubility

DMSO: 2 mg/mL, clear

solubility

-

solubility

ethanol: soluble 2.6 mg/mL, 0.1 M HCl: soluble 7 mg/mL, H2O: soluble >10 mg/mL

storage condition

desiccated

storage condition

desiccated

storage condition

-

storage condition

desiccated

originator

Abbott

originator

-

originator

Schering Plough

originator

-


pictograms

Skull and crossbones

signalword

Danger

Hazard Classifications

Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral

Classe di stoccaggio

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



Questions

Reviews

No rating value

Active Filters